Ledger.Open graph →
SEC Form D · filed March 9, 2023

Io Therapeutics, Inc

Offering
$4.2M
Sold
$4.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SPRING, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Vidyasagar Vuligonda · SPRING, TXExecSahani Chandraratna · SPRING, TXDirectorMartin Sanders · SPRING, TXExecSharon Lew · SPRING, TXExecDavid Wurtzbacher · Arlington, VADirectorMark Strauch · Arlington, VAExecDavid Fulcher · Arlington, VAExecErin Stahmer · Arlington, VAExecMichael Widmann · Menlo Park, CADirectorMichelle Ngo · Scottsdale, AZExecOliver M. Murray · La Jolla, CAExecChris Mccoy · COVINA, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗